Literature DB >> 30004858

Cellular Components and Mechanisms of Oral Tolerance Induction.

Rafael M Rezende1, Howard L Weiner1.   

Abstract

Oral tolerance can be defined as an inhibition of specific immune responsiveness to subsequent parenteral injections of proteins to which an individual or animal has been previously exposed via the oral route. Multiple mechanisms of tolerance are induced by oral-fed antigens, but induction of regulatory CD4 T-cells expressing the transcription factor Foxp3 and the membrane-bound TGF-β stands out as the major players in oral tolerance. Oral antigen administration suppresses several animal models of autoimmune disease, including experimental autoimmune encephalomyelitis, uveitis, thyroiditis, myasthenia, arthritis, and diabetes, but also nonautoimmune inflammatory conditions such as asthma, atherosclerosis, graft rejection, allergy, and stroke. However, human trials have produced mixed results, and a great deal remains to be learned about the mechanisms of oral tolerance before it can be successfully applied to people. In this review, we highlight the cellular components involved in oral tolerance induction. A deep knowledge of these intricate cell interactions will pave the way for a successful application of antigen tolerance to treat autoimmune and nonautoimmune inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30004858     DOI: 10.1615/CritRevImmunol.2018026181

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  5 in total

1.  LAP+ Cells Modulate Protection Induced by Oral Vaccination with Rhesus Rotavirus in a Neonatal Mouse Model.

Authors:  Laura María Rey; José Ángel Gil; José Mateus; Luz-Stella Rodríguez; Martín Alonso Rondón; Juana Ángel; Manuel Antonio Franco
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

2.  Hsp65-Producing Lactococcocus lactis Prevents Antigen-Induced Arthritis in Mice.

Authors:  Guilherme Gusmao-Silva; Sarah Leão Fiorini Aguiar; Mariana Camila Gonçalves Miranda; Mauro Andrade Guimarães; Juliana Lima Alves; Angélica Thomaz Vieira; Denise Carmona Cara; Anderson Miyoshi; Vasco Ariston Azevedo; Rafael Pires Oliveira; Ana Maria Caetano Faria
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

3.  γδ T Cell-Secreted XCL1 Mediates Anti-CD3-Induced Oral Tolerance.

Authors:  Rafael M Rezende; Brenda N Nakagaki; Thais G Moreira; Juliana R Lopes; Chantal Kuhn; Bruna K Tatematsu; Selma Boulenouar; Amir-Hadi Maghzi; Stephen Rubino; Gustavo B Menezes; Tanuja Chitnis; Howard L Weiner
Journal:  J Immunol       Date:  2019-10-02       Impact factor: 5.422

4.  Preclinical development of plant-based oral immune modulatory therapy for haemophilia B.

Authors:  Aparajitha Srinivasan; Roland W Herzog; Imran Khan; Alexandra Sherman; Thais Bertolini; Tung Wynn; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2021-05-15       Impact factor: 13.263

Review 5.  Oral tolerance as antigen-specific immunotherapy.

Authors:  Natália Pinheiro-Rosa; Lícia Torres; Mariana de Almeida Oliveira; Marcos Felipe Andrade-Oliveira; Mauro Andrade de Freitas Guimarães; Monique Macedo Coelho; Juliana de Lima Alves; Tatiani Uceli Maioli; Ana M Caetano Faria
Journal:  Immunother Adv       Date:  2021-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.